Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Pharmacokinetics of ceftriaxone in freshwater crocodiles (Crocodylus siamensis) after intramuscular administration at two dosages.

Tytuł :
Pharmacokinetics of ceftriaxone in freshwater crocodiles (Crocodylus siamensis) after intramuscular administration at two dosages.
Autorzy :
Poapolathep S; Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand.
Giorgi M; Department of Veterinary Sciences, University of Pisa, San Piero a Grado, Italy.
Chaiyabutr N; Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
Klangkaew N; Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand.
Phaochoosak N; Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand.
Wongwaipairote T; Wongweerakij Crocodile Farm, Bo Phloi, Kanjanaburi, Thailand.
Poapolathep A; Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand.
Pokaż więcej
Źródło :
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2020 Mar; Vol. 43 (2), pp. 141-146. Date of Electronic Publication: 2019 Jul 29.
Typ publikacji :
Journal Article; Randomized Controlled Trial, Veterinary
Język :
Imprint Name(s) :
Original Publication: Oxford, Blackwell Scientific Publications.
MeSH Terms :
Alligators and Crocodiles/*blood
Anti-Bacterial Agents/*pharmacokinetics
Animals ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/blood ; Area Under Curve ; Ceftriaxone/administration & dosage ; Ceftriaxone/blood ; Dose-Response Relationship, Drug ; Half-Life ; Hemangioma
References :
Albarellos, G. A., Kreil, V. E., & Landoni, M. F. (2007). Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats. Journal of Veterinary Pharmacology and Therapeutics, 30, 345-352.
Balant, L., Dayer, P., & Auckenthaler, R. (1985). Clinical pharmacokinetics of the third generation cephalosporins. Clinical Pharmacokinetics, 10, 101-143.
Baldo, B. A. (2000). Diagnosis of allergy to penicillins and cephalosporins. Allergy & Clinical Immunology International - Journal of the World Allergy Organization, 12, 206-212.
Benet, L. Z., & William, R. L. (1991) Design and optimization of dosage regimen: pharmacokinetic data. In: A. G. Gilman, J. W. Rall, A. S. Niles, & P. Taylor (Eds.), Goodman and Gilman’s the pharmacological basis of therapeutics, 8th ed., vol. 2, (pp. 1666). Singapore: Maxwell Macmillan.
Cavalier, A., Leveque, D., Peter, J. D., Salmon, J., Elkhaili, H., Salmon, Y., … Jehl, F. (1997). Pharmacokinetic interaction between itraconazole and ceftriaxone in Yucatan miniature pigs. Antimicrobial Agents and Chemotherapy, 41, 2029-2032.
Craig, A. W., & Suh, B. (1980). Protein binding and the antibacterial effects. Method for determination of protein binding. In V. Lorian (Ed.), Antibiotics in Laboratory Medicine (pp. 265-297). Williams and Wilkins, Baltimore: MD.
Dardi, M. S., Sharma, S. K., & Srivastav, A. K. (2004). Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves. Veterinary Research Communications, 28, 331-338.
Dardi, M. S., Sharma, S. K., & Srivastav, A. K. (2005). Pharmacokinetics and dosage regimen of ceftriaxone in E. coli lipopolysaccharide induced fever in buffalo calves. Journal of Veterinary Science, 6, 147-150.
Goudah, A. (2008). Pharmacokinetic parameters of ceftriaxone after single intravenous and intramuscular administration in camel (Camelus dromedaries). Research in Veterinary Science, 84, 483-489.
Gougah, A., Shin, H. C., Shim, J. H., & Abd El-Aty, A. M. (2006). Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes. Journal of Veterinary Pharmacology and Therapeutics, 29, 307-312.
Guerrini, V. H., Filippich, L. J., Cao, G. R., English, P. B., & Bourne, D. W. A. (1985). Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep. Journal of Veterinary Pharmacology and Therapeutics, 8, 120-127.
Helmick, K. E., Papich, M. G., Vliet, K. A., Bennett, R. A., & Jacobson, E. R. (2004). Pharmacokinetics of enrofloxacin after single-dose oral and intravenous administration in the American alligator (Alligator mississippiensis). Journal of Zoo and Wildlife Medicine, 35, 333-340.
Hidefumi, M., Komiya, M., Lkeda, C., & Tachibana, A. (1984). Comparative pharmacokinetics of YM-13115, ceftriaxone and ceftazidime in rats, dogs and rhesus monkeys. Antimicrobial Agents and Chemotherapy, 26, 204-207.
Ismail, M. M. (2005). Pharmacokinetics, urinary and mammary excretion of ceftriaxone in lactating goats. Journal of Veterinary Medicine Series A, 52, 354-358.
Johal, B., & Srivastava, A. K. (1998). Pharmacokinetics, urinary excretion and dosage regimen of ceftriaxone in crossbred cow calves following single muscular administration. Indian Journal of Animal Science, 68, 1017-1019.
Johal, B., & Srivastava, A. K. (1999). Disposition kinetics and dosage regimen of ceftriaxone in crossbred calves. Acta Veterinaria Hungarica, 47, 243-248.
Knudsen, J. D., Frimodt-Moller, N., & Espersen, F. (1995). Experimental Streptococcus pneumonia infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy, 39, 1253-1258.
Kovar, A., Dalla Costa, T., & Derendorf, H. (1997). Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis. Journal of Pharmaceutical Sciences, 86, 52-56. htttps://
Lamb, H. M., Ormrod, D., Scott, L. J., & Figgitt, D. P. (2002). Ceftriaxone: An update of its use in The management of community-acquired and nosocomial infection. Drugs, 62, 1041-1089. htttps://
Liu, P., Muller, M., & Derendorf, H. (2002). Rational dosing of antibiotics: The use of plasma concentrations versus tissue concentrations. International Journal of Antimicrobial Agents, 17, 383-387. htttps://, 00024-9.
Mapongpeng, R., Laovechprasit, W., Poapolathep, A., Giorgi, M., Junchompoo, C., Sakulthaew, C., … Poapolathep, S. (2019). Pharmacokinetics of ceftriaxone in Green sea turtles (Chelonia mydas) following intravenous and intramuscular administration at two dosages. Journal of Veterinary Pharmacology and Therapeutics, 42, 104-110.
Martelli, P., Lai, O. R., Krishnasamy, K., Langelet, E., Marín, P., Laricchiuta, P., & Crescenzo, G. (2009). Pharmacokinetic behavior of enrofloxacin in Estuarine crocodile (Crocodylus porosus) after single intravenous, intramuscular, and oral doses. Journal of Zoo and Wildlife Medicine, 40, 696-704.
Plumb, D. C. (2015). Plumb’s veterinary drug handbook, 8th ed. (pp. 262-264). Ames, IA: Willey-Blackwell.
Poapolathep, S., Giorgi, M., Hantrakul, S., Klangkaew, N., Sanyathitiseree, P., & Poapolathep, A. (2017). Pharmacokinetics of marbofloxacin in freshwater crocodiles (Crocodylus siamensis) after intravenous and intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 40, 57-61.
Rebuelto, M., Albarellos, G., Ambros, L., Kreil, V., Montoya, L., Bonafine, R., … Hallu, R. (2002). Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs. Journal of Veterinary Pharmacology and Therapeutics, 25, 73-76.
Ringger, N. C., Brown, M. P., Kohlepp, S. J., Growall, R. R., & Merrit, K. (1998). Pharmacokinetics of ceftriaxone in neonatal foals. Equine Veterinary Journal, 30, 163-165.
Ringger, N. C., Pearson, E. G., Gronwell, R., & Kohlepp, S. L. (1996). Pharmacokinetics of ceftriaxone in healthy horses. Equine Veterinary Journal, 28, 476-479.
Seddon, M., Wise, R., Gillett, A. P., & Livingston, R. (1980). Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy, 18, 240-242.
Soback, S., & Ziv, G. (1988). Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly in calves. American Journal of Veterinary Research, 49, 535-538.
Toutain, P. L., & Bouqsuet-Melou, A. (2004). Plasma terminal half-life. Journal of Veterinary Pharmacology and Therapeutics, 27, 427-439.
Toutain, P. L., Del Castillo, J. R. E., & Bousquet-Melou, A. (2002). The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73, 105-114.
Wright, D. F. B., Winter, H. R., & Duffull, S. D. (2011). Understanding the time course of pharmacological effect: A PKPD approach. British Journal of Clinical Pharmacology, 71, 815-823.
Grant Information :
: RSA6180033 Thailand Research Fund
Contributed Indexing :
Keywords: LC-MS/MS; ceftriaxone; freshwater crocodiles; pharmacokinetics
Substance Nomenclature :
0 (Anti-Bacterial Agents)
75J73V1629 (Ceftriaxone)
Entry Date(s) :
Date Created: 20190730 Date Completed: 20201209 Latest Revision: 20201214
Update Code :
Czasopismo naukowe
One of the major obstacles to the successful treatment of infectious disease in freshwater crocodile species is incorrect dosing of antibiotics. There are few reports on pharmacokinetics and dosage regimens of antimicrobial drugs in crocodiles. The purpose of the present study was to clarify the pharmacokinetic characteristics of ceftriaxone (CEF) in Siamese freshwater crocodiles (Crocodylus siamensis). Freshwater crocodiles, Crocodylus siamensis, in breeding farms were treated with a single intramuscular administration of CEF at two dosages, 12.5 and 25 mg/kg body weight (b.w.). Blood samples were collected at preassigned times up to 168 hr. The plasma concentrations of CEF were measured by a validated method through liquid chromatography tandem-mass spectrometry. CEF plasma concentrations were quantified up to 72 and 96 hr after low- and high-dose administration, respectively. The C max values of CEF were 24.61 ± 5.15 µg/ml and 26.39 ± 2.81 µg/ml at dosages of 12.5 and 25 mg/kg b.w., respectively. The AUC last values increased in a dose-dependent fashion. The half-life values were not statistically different between the groups (around 20 hr). The average binding percentage of CEF to plasma protein was 53.78 ± 2.11%. Based on the pharmacokinetic data, susceptibility break-point and the surrogate PK-PD index (T > MIC, 0.2 μg/ml), i.m. administration of CEF at a dose of 12.5 mg/kg b.w. might be appropriate for initiating treatment of susceptible bacterial infections in freshwater crocodiles.
(© 2019 John Wiley & Sons Ltd.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies